Physician profile
Nicholas J Frame
NPI 1457588402
$2,995.54
in general payments reported to CMS, 2019-2025
16 companies · $1,329 in 2025
The $1,329 reported for 2025 was more than what 83% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $215 · 2020: $89.89 · 2021: $286 · 2022: $460 · 2023: $306 · 2024: $310 · 2025: $1,329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,012 · Charitable Contribution: $900 · Honoraria: $32.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,012.25 |
| Charitable Contribution | $899.88 |
| Honoraria | $32.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microsurgical Technology, INC. | $899.88 | 2025 | |
| Abbvie INC. | $680.02 | 2022-2025 | |
| Alcon Vision LLC | $551.76 | 2019-2025 | Hydrus Microstent, Ngenuity |
| Allergan, INC. | $155.75 | 2020-2021 | |
| Ivantis, INC | $150.38 | 2019 | |
| Glaukos Corporation | $140.17 | 2022 | |
| New World Medical,INC. | $134.74 | 2021-2025 | Ahmed Glaucoma Valve, Streamline, Clearpath |
| Thea Pharma INC. | $63.14 | 2024 | Iyuzeh |
| Rxsight INC | $46.69 | 2024-2025 | Light Adjustable Lens (Lal), Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd) |
| Tarsus Pharmaceuticals, INC. | $43.31 | 2024-2025 | Xdemvy |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Sight Sciences, INC. | $24.15 | 2019 | |
| Dompe US, INC. | $20.13 | 2025 | Oxervate |
| Omeros Corporation | $17.02 | 2020 | |
| Oyster Point Pharma, INC. | $15.60 | 2023 | Tyrvaya |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumibird Medical INC. | $14.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Frame listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.